Search Results - Rolf Kaiser
- Showing 1 - 20 results of 41
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Predicting Response to Antiretroviral Treatment by Machine Learning: The EuResist Project by Maurizio Zazzi, Francesca Incardona, Michal Rosen‐Zvi, Mattia Prosperi, Thomas Lengauer, André Altmann, Anders Sönnerborg, Tamar Lavee, Eugen Schülter, Rolf Kaiser
Published 2012Revisão -
7
-
8
-
9
-
10
Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication by J P Kleim, R. Bender, Reinhard Kirsch, C Meichsner, Arno Paessens, Manfred Rösner, Helga Rübsamen‐Waigmann, Rolf Kaiser, M. Wichers, K. E. Schneweis
Published 1995Artigo -
11
-
12
Predicting HIV Coreceptor Usage on the Basis of Genetic and Clinical Covariates by Tobias Sing, Andrew Low, Niko Beerenwinkel, Oliver Sander, Peter K. Cheung, Francisco S. Domingues, Joachim Büch, Martin Däumer, Rolf Kaiser, Thomas Lengauer, P. Richard Harrigan
Published 2007Artigo -
13
Trends of Transmitted and Acquired Drug Resistance in Europe From 1981 to 2019: A Comparison Between the Populations of Late Presenters and Non-late Presenters by Mafalda Miranda, Marta Pingarilho, Victor Pimentel, Maria do Rosário Oliveira Martins, Rolf Kaiser, Carole Seguin‐Devaux, Roger Paredes, Maurizio Zazzi, Francesca Incardona, Ana Abecasis
Published 2022Artigo -
14
-
15
Primary HIV Drug Resistance and Efficacy of First-Line Antiretroviral Therapy Guided by Resistance Testing by Mark Oette, Rolf Kaiser, Martin Däumer, Ruth Petch, Gerd Fätkenheuer, Horst Carls, Jürgen K. Rockstroh, Dirk Schmalöer, Jürgen Stechel, Torsten Feldt, Herbert Pfister, Dieter Häussinger
Published 2006Artigo -
16
High rate of RNAemia and impaired immunity in patients with immunodeficiency in the vaccination era by Anne Thierbach, Veronica Di Cristanziano, Kirsten Alexandra Eberhardt, Martin Pirkl, Gertrud Steger, Eva Heger, Rolf Kaiser, Manuel Koch, Florian Klein, Dominic Rauschning, Jakob J Malin
Published 2025Artigo -
17
geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data by Matthias Döring, Joachim Büch, Georg Friedrich, Alejandro Pironti, Prabhav Kalaghatgi, Elena Knops, Eva Heger, Martin Obermeier, Martin Däumer, Alexander Thielen, Rolf Kaiser, Thomas Lengauer, Nico Pfeifer
Published 2018Artigo -
18
CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality by Kirsten Alexandra Eberhardt, Verena Jung, Elena Knops, Eva Heger, Maike Wirtz, Gertrud Steger, Rolf Kaiser, Patrick Affeldt, Udo Holtick, Florian Klein, Christof Scheid, Veronica Di Cristanziano
Published 2023Artigo -
19
Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades by Tomas Doyle, David Dunn, Francesca Ceccherini‐Silberstein, Carmen de Mendoza, Frederico Garcia, Erasmus Smit, Esther Fearnhill, Anne‐Geneviève Marcelin, Javier Martínez‐Picado, Rolf Kaiser, Anna María Geretti
Published 2015Artigo -
20
Selecting anti-HIV therapies based on a variety of genomic and clinical factors by Michal Rosen‐Zvi, André Altmann, Mattia Prosperi, Ehud Aharoni, Hani Neuvirth, Anders Sönnerborg, Eugen Schülter, Daniel Struck, Yardena Peres, Francesca Incardona, Rolf Kaiser, Maurizio Zazzi, Thomas Lengauer
Published 2008Artigo
Search Tools:
Related Subjects
Virology
Biology
Medicine
Internal medicine
Human immunodeficiency virus (HIV)
Genetics
Virus
Immunology
Gene
Viral load
Antiretroviral therapy
Drug resistance
Computational biology
Computer science
Genotype
Pharmacology
Artificial intelligence
Microbiology
Viral disease
Antibody
Disease
Drug
Engineering
HIV drug resistance
Immune system
Transplantation
Demography
Ecology
Hematopoietic stem cell transplantation
Resistance (ecology)